VENTURE 17             - Private Education for the Medical Arts and Sciences
RSS Follow Become a Fan

Delivered by FeedBurner


Recent Posts

CORONA VIRUS UPDATES
Migraine Therapy Update
NET NEUTRALITY
LEUKEMIA, THE PARADIGM MIRACLE
MIGRAINES IN CHILDREN

Most Popular Posts

Stem Cell Research Stopped?
New Advancements in the Understanding and Treatment of Parkinson’s Disease
Is My Headache a Migraine?
Crohns Disease and Today's Athlete
Neurology Update: Normal Pressure Hydrocephalis

Categories

Arts and Photography
Business
Clinical Update
Education
Education and Political Action
Medical Advise
Medical History
Medical Law
Medical Opinion
Personal Fitness
Political Comment
Psychology
Recipes
Science Update
Social Comment
Special Post
Student Post
powered by

THE SEARCHLIGHT MESSENGER

Medical Opinion

MIGRAINES IN CHILDREN

Many of you have read my article on migraines entitled
Is My Headache a Migraine. Recently I have been approached with questions from my college campus students regarding their children and the brittle headaches their kids endure. Two students in particular stated that their child’s doctor had diagnosed them as having migraines, prescribed the medicine, periactin as needed, but did not explain to them what migraines in children are really all about.

This is a little disturbing to me, as I feel the more educated my patients are, the better they are able to manage their headaches and lead normal healthy lives.

Maintenance of Certification: Doctors Strike Back


Doctors Strike Back

Underlying much of the controversy surrounding Maintenance of Certification (MOC), is the question of how much, or even whether, the process as currently structured actually improves physician performance and/or patient outcomes.
 
On February 3, 2015, many physicians received a surprising email from Richard Baron, MD, MACP, president and chief executive officer of theAmerican Board of Internal Medicine(ABIM). Referring to the board’s controversial maintenance of certification (MOC) program, Baron wrote, “ABIM clearly got it wrong.

Maintenance of Certification Controversy Fueled by New Studies


Two recent studies in theJournal of the American Medical Associationare sparking fresh controversy over the effectiveness of, and need for, themaintenance of certification(MOC) requirements mandated by the American Board of Internal Medcine (ABIM.)

The studies inJAMA’s December 10 issue both look at MOC’s impact on the costs and quality of patient care, although in different ways. Thefirst study, led by ABIM’s Bradley Gray, Ph.D., compared costs and outcomes for two groups of Medicare beneficiaries during the years 1999-2005: one group treated by internists who received board certification in 1991, and were thus required to recertify in 2001, and a second group treated by internists who certified in 1989, and were thus grandfathered out of ABIM’s recertification requirements.

The Craziest Frivolous Malpractice Lawsuits


With their hands basically tied, what doctors didn't have in many states until recently, was the ability to counter sue to win back at least their legal fees after successfully defending a malpractice litigation.  It took decades to make changes to tort law, as most congressman lawmakers when not working in congress, are attorneys making money in "trial law". So they always slanted the law toward the consumer to guaranty their cash flow. Yeah, I know!

Remember that most lawsuits are pursued by most people because there is little or no financial risk to them.

The Ever Changing Screens For Breast Cancer

 
We’ve been seeing a lot of NFL players wearing pink this month. Every October, we celebrate our strides against breast cancer and push to make people aware of the disease and help hunt for a cure. Certainly, when efforts such as these have come before, we have been stalwart, and winners against cancer. All one has to do is look back on the 1960’s and see  the horrible disease that childhood leukemia was, and now, 95% survival rates and 60% remission rates are the rule. Or how about cervical and uterine cancer, and our success against this one time leading cause of cancer death in women, now controlled.